Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(0)
# 4603
Out of 5,218 analysts
257
Total ratings
27.18%
Success rate
-16.09%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Legend Biotech | Reiterates: Buy | 73 73 | 35.19 | 107.45% | 32 | Dec 10, 2024 | |
Metagenomi | Maintains: Strong Buy | 7 14 | 3.31 | 322.96% | 8 | Dec 10, 2024 | |
TC BioPharm (Holding... | Maintains: Buy | 7 3 | 0.52 | 476.92% | 3 | Dec 6, 2024 | |
Cartesian Therapeuti... | Reiterates: Strong Buy | 41 45 | 18.67 | 141.03% | 14 | Dec 4, 2024 | |
Sarepta Therapeutics | Maintains: Sell | 80 75 | 123.57 | -39.31% | 2 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 5 5 | 1.1 | 354.55% | 16 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 8 5 | 0.4 | 1150% | 11 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 55 55 | 23.4 | 135.04% | 13 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 45 45 | n/a | n/a | 3 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 68 68 | 47.98 | 41.73% | 28 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 115 115 | 46.49 | 147.37% | 10 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 7 6 | 4.41 | 36.05% | 5 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 9 9 | 1.65 | 445.45% | 14 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 44 44 | 17.89 | 145.95% | 11 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 5 5 | 2.29 | 118.34% | 4 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 110 110 | 21.94 | 401.37% | 13 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 21 23 | 6.92 | 232.37% | 5 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 30 26 | 8.43 | 208.42% | 2 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 1 1 | 0.68 | 47.06% | 10 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 32 30 | 14.96 | 100.53% | 16 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | n/a | n/a | n/a | 6 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 15 14 | 5.72 | 144.76% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 9 5 | 1.22 | 309.84% | 14 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 15 15 | n/a | n/a | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 160 2440 | 0.34 | 717547.06% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | n/a | n/a | n/a | 4 | Jun 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 35 36 | n/a | n/a | 4 | Nov 22, 2022 |